Rapid adoption of newer, more expensive prostate cancer treatments found, without proof of cost-effectiveness

Newer, more expensive treatment options for prostate cancer were adopted rapidly and widely during 2002-2005 without proof of their cost-effectiveness, and may offer explanations for why health care spending accounts for 17 percent of the nation's GDP.

Read the whole article on Science Daily

More from Science Daily